Category: low libido in women
Jean Hailes: Jean Hailes Magazine Vol. 1, 2021: Sex, anti-inflammatory foods, PMDD
From go to ‘ohh!’: Sex across the lifespan Through the course of a lifetime, a person’s sex life will ebb and flow. It can… Continue Reading →
Jean Hailes: Sex & Menopause
Sex & Menopause Menopause can affect your relationships and your sex life. Symptoms such as a dry vagina can make sex painful and you… Continue Reading →
What is HSDD?
What is HSDD? Hypoactive sexual desire dysfunction (HSDD) is an extremely common medical condition that causes distress resulting from a low sexual desire. Clinical… Continue Reading →
IMS: Sexual wellbeing after menopause
Patient Support Material: Free yourself and embrace positive sexual wellbeing Sexual health is a state of physical, emotional, mental and social wellbeing related to… Continue Reading →
IMS: Sexual wellbeing after menopause
Free yourself and embrace positive sexual wellbeing Sexual health is a state of physical, emotional, mental and social wellbeing related to sexuality. After menopause… Continue Reading →
AndroFeme 1 included on ARTG for hypoactive sexual desire dysfunction in postmenopausal women
Lawley Pharmaceuticals’ female-specific hormone cream, AndroFeme® 1, has been registered on the Australian Register of Therapeutic Goods (ARTG) for the treatment of postmenopausal women… Continue Reading →
AndroFeme 1 licensed for hypoactive sexual desire dysfunction in postmenopausal women
Lawley Pharmaceuticals has obtained approval for registration of AndroFeme® 1 in the Australian Register of Therapeutic Goods (ARTG) for the treatment of postmenopausal women… Continue Reading →
Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1
Friday 12th June 2020 Perth, Australia and Charlotte, USA – Lawley Pharmaceuticals and Tanner Pharma Group announced today that they have initiated a global… Continue Reading →
Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1
Friday 12th June 2020 Perth, Australia and Charlotte, USA – Lawley Pharmaceuticals and Tanner Pharma Group announced today that they have initiated a global… Continue Reading →
TGA accepts AndroFeme 1 for evaluation in postmenopausal women with Hypoactive Sexual Desire Dysfunction.
TGA accepts AndroFeme 1 for evaluation in postmenopausal women with HSDD. Perth, Western Australia; Dec. 05, 2019 — Lawley Pharmaceuticals today announced AndroFeme 1,… Continue Reading →